85 related articles for article (PubMed ID: 8076370)
1. Determination of DNA topoisomerase II in newly diagnosed childhood acute lymphoblastic leukemia by immunocytochemistry and RT-PCR.
Stammler G; Sauerbrey A; Volm M
Cancer Lett; 1994 Sep; 84(2):141-7. PubMed ID: 8076370
[TBL] [Abstract][Full Text] [Related]
2. Messenger RNA expression of resistance factors and their correlation to the proliferative activity in childhood acute lymphoblastic leukemia.
Stammler G; Sauerbrey A; Volm M
Cancer Lett; 1995 Feb; 89(1):129-35. PubMed ID: 7882295
[TBL] [Abstract][Full Text] [Related]
3. Single-strand conformational polymorphism analysis of the M(r) 170,000 isozyme of DNA topoisomerase II in human tumor cells.
Danks MK; Warmoth MR; Friche E; Granzen B; Bugg BY; Harker WG; Zwelling LA; Futscher BW; Suttle DP; Beck WT
Cancer Res; 1993 Mar; 53(6):1373-9. PubMed ID: 8383009
[TBL] [Abstract][Full Text] [Related]
4. Topoisomerase II alpha gene expression in childhood acute lymphoblastic leukemia.
Klumper E; Giaccone G; Pieters R; Broekema G; van Ark-Otte J; van Wering ER; Kaspers GJ; Veerman AJ
Leukemia; 1995 Oct; 9(10):1653-60. PubMed ID: 7564505
[TBL] [Abstract][Full Text] [Related]
5. Modification of topoisomerase genes copy number in newly diagnosed childhood acute lymphoblastic leukemia.
Guérin E; Entz-Werlé N; Eyer D; Pencreac'h E; Schneider A; Falkenrodt A; Uettwiller F; Babin A; Voegeli AC; Lessard M; Gaub MP; Lutz P; Oudet P
Leukemia; 2003 Mar; 17(3):532-40. PubMed ID: 12646941
[TBL] [Abstract][Full Text] [Related]
6. Topoisomerase II alpha and II beta expression in childhood acute lymphoblastic leukaemia: relation to prognostic factors and clinical outcome.
Lodge AJ; Hall AG; Reid MM; McIntosh GG; Steward M; Anderson JJ; Horne CH; Angus B
J Clin Pathol; 2001 Jan; 54(1):31-6. PubMed ID: 11271785
[TBL] [Abstract][Full Text] [Related]
7. Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.
Gekeler V; Frese G; Noller A; Handgretinger R; Wilisch A; Schmidt H; Muller CP; Dopfer R; Klingebiel T; Diddens H
Br J Cancer; 1992 Sep; 66(3):507-17. PubMed ID: 1355660
[TBL] [Abstract][Full Text] [Related]
8. Relationship of DNA topoisomerase II alpha and beta expression to cytotoxicity of antineoplastic agents in human acute lymphoblastic leukemia cell lines.
Brown GA; McPherson JP; Gu L; Hedley DW; Toso R; Deuchars KL; Freedman MH; Goldenberg GJ
Cancer Res; 1995 Jan; 55(1):78-82. PubMed ID: 7805045
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of protein kinase C, proto-oncogene products and resistance-related proteins in newly diagnosed childhood acute lymphoblastic leukemia.
Volm M; Zintl F; Edler L; Sauerbrey A
Med Pediatr Oncol; 1997 Feb; 28(2):117-26. PubMed ID: 8986147
[TBL] [Abstract][Full Text] [Related]
10. Expression of mdr1, mrp, topoisomerase II alpha/beta, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias.
Beck J; Handgretinger R; Dopfer R; Klingebiel T; Niethammer D; Gekeler V
Br J Haematol; 1995 Feb; 89(2):356-63. PubMed ID: 7873386
[TBL] [Abstract][Full Text] [Related]
11. Level of DNA topoisomerase IIalpha mRNA predicts the treatment response of relapsed acute leukemic patients.
Wang YH; Takanashi M; Tsuji K; Tanaka N; Shiseki M; Mori N; Motoji T
Leuk Res; 2009 Jul; 33(7):902-7. PubMed ID: 19185918
[TBL] [Abstract][Full Text] [Related]
12. Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide.
Bugg BY; Danks MK; Beck WT; Suttle DP
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7654-8. PubMed ID: 1652758
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of DNA topoisomerase II alpha messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assay.
Withoff S; Smit EF; Meersma GJ; van den Berg A; Timmer-Bosscha H; Kok K; Postmus PE; Mulder NH; de Vries EG; Buys CH
Lab Invest; 1994 Jul; 71(1):61-6. PubMed ID: 8041119
[TBL] [Abstract][Full Text] [Related]
14. Method for quantifying expression of functionally active topoisomerase II in patients with leukaemia.
Cattan AR; Levett D; Douglas EA; Middleton PG; Taylor PR
J Clin Pathol; 1996 Oct; 49(10):848-52. PubMed ID: 8943755
[TBL] [Abstract][Full Text] [Related]
15. [Study on the relationship between DNA topoisomerase II activity and multidrug resistance in leukemic cells].
Zheng W; Xie Z; Tang G
Zhonghua Xue Ye Xue Za Zhi; 1998 Sep; 19(9):470-2. PubMed ID: 11189486
[TBL] [Abstract][Full Text] [Related]
16. Detection of fos, jun and ras in newly-diagnosed childhood acute lymphoblastic-leukemia by immunocytochemistry and PCR.
Volm M; Sauerbrey A; Stammler G; Zintl F
Int J Oncol; 1994 Jun; 4(6):1251-6. PubMed ID: 21567045
[TBL] [Abstract][Full Text] [Related]
17. Topoisomerase II alpha mRNA and tumour cell proliferation in non-Hodgkin's lymphoma.
Lohri A; Reuter J; Gudat F; Herrmann R
J Clin Pathol; 1997 Jan; 50(1):22-6. PubMed ID: 9059350
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line.
Harker WG; Slade DL; Parr RL; Feldhoff PW; Sullivan DM; Holguin MH
Cancer Res; 1995 Apr; 55(8):1707-16. PubMed ID: 7712479
[TBL] [Abstract][Full Text] [Related]
19. DNA topoisomerase II alpha gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells.
Kubo T; Kohno K; Ohga T; Taniguchi K; Kawanami K; Wada M; Kuwano M
Cancer Res; 1995 Sep; 55(17):3860-4. PubMed ID: 7641205
[TBL] [Abstract][Full Text] [Related]
20. DNA topoisomerase II immunostaining in human leukemia and rhabdomyosarcoma cell lines and their responses to topoisomerase II inhibitors.
Wolverton JS; Danks MK; Granzen B; Beck WT
Cancer Res; 1992 Aug; 52(15):4248-53. PubMed ID: 1322239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
